Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-11-03
1990-08-07
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549 23, A61K 3138, C07D33506
Patent
active
049468600
ABSTRACT:
Disclosed are novel benzothiopyranyl derivatives as 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors useful as antihypercholesterolemic agents represented by the formula: ##STR1## their corresponding dihydroxy acids, and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 4282155 (1981-08-01), Smith et al.
patent: 4611067 (1986-09-01), Volante et al.
patent: 4668699 (1987-05-01), Hoffman et al.
patent: 4897402 (1990-01-01), Duggan et al.
Barton Jeffrey N.
Morris Robert L.
Balogh Imre (Jim)
Howard M. S.
Lee Mary C.
Nicholson James A.
Rorer Pharmaceutical Corporation
LandOfFree
Benzothiopyranyl derivatives as HMG-CoA reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzothiopyranyl derivatives as HMG-CoA reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothiopyranyl derivatives as HMG-CoA reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-960909